ESH/LinkedIn
Mar 3, 2026, 15:16
Transplant vs CAR T Cells in Multiple Myeloma Debate at ESHMM 2026 – ESH
European School of Haematology (ESH) shared a post on LinkedIn:
“Programme Highlight of ESHMM 2026!
Debate 3 – Transplant vs CAR T cells.
Moderated by Martin Kaiser with Mohamad Mohty and Robert Orlowski (with audience voting)
Less than a month to go before the conference begins!
Secure your spot today — Register now and Join us on March 26-28, 2026 in Stockholm, Sweden.
8th Translational Research Conference on Multiple Myeloma.
Conference Chairs: Hartmut Goldschmidt, Martin Kaiser, Suzanne Lentzsch”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 18:13Wolfgang Miesbach: Hereditary Hemorrhagic Telangiectasia An Overlooked Bleeding Disorder
-
Oct 21, 2026, 17:55Gayatri Kotwal։ New Review on Anemia, Pain, and Nutritional Deficiencies in Cancer Patients
-
Oct 21, 2026, 17:40Tetsuzan Ron: Iron Deficiency Without Anemia Clinical Impact and Management
-
Oct 21, 2026, 17:29Amir Hossien Esfandiari։ The Association Between Viral Infections and Aplastic Anemia
-
Oct 21, 2026, 17:16Melissa Hollo: A Meaningful Step Forward for Women’s Health
-
Oct 21, 2026, 17:09Chipili Ng’onga: Have You Ever Seen a Result That Just Didn’t Make Sense?
-
Oct 21, 2026, 16:57Fabrice Cognasse: Celebrating the Next Generation of Platelet Research and Transfusion Medicine
-
Oct 21, 2026, 16:47Christabel Odeta: Treating Pediatric Cancer in Children With Sickle Cell Disease
-
Oct 21, 2026, 16:36Sharlene Haywood: Bringing Multidisciplinary Learning Into Nursing Practice